Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Augmentation of natural killer cell activity in vitro and in vivo by sericin-derived oligopeptides

Pornpimon Jantaruk, Porkaew Promphet, Manote Sutheerawattananonda, Duangkamol Kunthalert

. 2015 ; 13 (3) : 249-256.

Language English Country Czech Republic

Persistent link   https://www.medvik.cz/link/bmc15030074

This study investigated the effects of sericin-derived oligopeptides on natural killer (NK) activity. In vitro exposure of human peripheral blood mononuclear cells with sericin-derived oligopeptides resulted in an augmentation of NK cell activity against K562 target cells and the effects appeared to be dose-related. Experiments designed to examine whether enhanced NK activity was due to direct or indirect activation of NK cells revealed that sericin oligopeptides did not induce activity of purified NK cells, and that sericin oligopeptides augmented NK activity indirectly by inducing the production of IL-2 and IFN-γ cytokines. In in vivo experimentation where mice were orally administered with sericin oligopeptides and splenic mononuclear cells tested against YAC-1 target cells, significant increase in NK activity was obtained compared to control mice. Elevated levels of IL-2 were also evident in all oligopeptides-treated groups. As demonstrated both in vitro and in vivo, these results indicate that sericin-derived oligopeptides have efficient NK-enhancing activity and suggest the potential therapeutic applications of such oligopeptides for functional improvement of NK cells, and possibly for treatment of tumor and infectious diseases in which NK activity contributes to host defense.

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc15030074
003      
CZ-PrNML
005      
20160131172938.0
007      
ta
008      
150922s2015 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jab.2015.03.005 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Jantaruk, Pornpimon $u Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
245    10
$a Augmentation of natural killer cell activity in vitro and in vivo by sericin-derived oligopeptides / $c Pornpimon Jantaruk, Porkaew Promphet, Manote Sutheerawattananonda, Duangkamol Kunthalert
504    __
$a Literatura
520    9_
$a This study investigated the effects of sericin-derived oligopeptides on natural killer (NK) activity. In vitro exposure of human peripheral blood mononuclear cells with sericin-derived oligopeptides resulted in an augmentation of NK cell activity against K562 target cells and the effects appeared to be dose-related. Experiments designed to examine whether enhanced NK activity was due to direct or indirect activation of NK cells revealed that sericin oligopeptides did not induce activity of purified NK cells, and that sericin oligopeptides augmented NK activity indirectly by inducing the production of IL-2 and IFN-γ cytokines. In in vivo experimentation where mice were orally administered with sericin oligopeptides and splenic mononuclear cells tested against YAC-1 target cells, significant increase in NK activity was obtained compared to control mice. Elevated levels of IL-2 were also evident in all oligopeptides-treated groups. As demonstrated both in vitro and in vivo, these results indicate that sericin-derived oligopeptides have efficient NK-enhancing activity and suggest the potential therapeutic applications of such oligopeptides for functional improvement of NK cells, and possibly for treatment of tumor and infectious diseases in which NK activity contributes to host defense.
650    12
$a buňky NK $x cytologie $x účinky léků $7 D007694
650    12
$a fyziologie buňky $x imunologie $x účinky léků $7 D002468
650    12
$a krevní buňky $x cytologie $x enzymologie $x účinky léků $7 D001773
650    _2
$a sericiny $x izolace a purifikace $x účinky léků $7 D047030
650    _2
$a oligopeptidy $x účinky léků $7 D009842
650    _2
$a interferon gama $x terapeutické užití $7 D007371
650    _2
$a interleukin-2 $x terapeutické užití $7 D007376
650    _2
$a cytokiny $x terapeutické užití $x účinky léků $7 D016207
650    _2
$a nádorové buněčné linie $x účinky léků $7 D045744
650    _2
$a buňky K562 $x cytologie $x účinky léků $7 D020014
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    _2
$a zvířata $7 D000818
650    _2
$a statistika jako téma $7 D013223
650    _2
$a techniky in vitro $7 D066298
650    _2
$a biomedicínský výzkum $7 D035843
653    00
$a buňky YAC-1
653    00
$a in vivo
700    1_
$a Promphet, Porkaew $u Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
700    1_
$a Sutheerawattananonda, Manote $u School of Food Technology, Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand
700    1_
$a Kunthalert, Duangkamol $u Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand; Centre of Excellence in Medical Biotechnology, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand
773    0_
$t Journal of applied biomedicine $x 1214-021X $g Roč. 13, č. 3 (2015), s. 249-256 $w MED00012667
856    41
$u https://jab.zsf.jcu.cz/pdfs/jab/2015/03/10.pdf $y plný text volně přístupný
910    __
$a ABA008 $b B 2301 $c 1249 $y 4 $z 0
990    __
$a 20150522215938 $b ABA008
991    __
$a 20160131173059 $b ABA008
999    __
$a ok $b bmc $g 1091017 $s 913169
BAS    __
$a 3
BMC    __
$a 2015 $b 13 $c 3 $d 249-256 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
LZP    __
$c NLK184 $d 20160131 $a NLK 2015-40/dk

Find record

Citation metrics

Archiving options